American College of Neuropsychopharmacology Inc. Neuropsychopharmacology
subscribe to npp
SEARCH
Advanced search
My Account E-alerts Subscribe Register Help
Journal home
Current Issue
Advance Online Publication
Archive
Online sample issue FREE!
Author index
Keyword index
For authors
Editorial Board
Instructions for authors
Aims and scope
Indexed in
Author queries
Online Submission
Customer Services
Subscription information
Journal prices
Order sample issue
Purchase articles,
reprints & permissions
Advertising
Contact NPG
nature.com
Neuropsychopharmacology (1996) 15 555-561.

beta-Adrenoceptor-Linked Protein Kinase A (PKA) Activity in Human Fibroblasts from Normal Subjects and from Patients with Major Depression

D Hal Manier MS1, Andrea Eiring BS1, Richard C Shelton MD1,2 and Fridolin Sulser MD1,2
1From the Departments of Psychiatry, Vanderbilt University School of Medicine, Nashville, Tennessee
2Departments of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee

Correspondence: Fridolin Sulser, MD, Vanderbilt University School of Medicine, AA-2232 MCN, Nashville, TN 37232

ABSTRACT

Human fibroblasts from normal subjects and from patients with major depression are cultured and their beta-adrenoreceptor-cyclic AMP-protein kinase A (PKA) system characterized. The results indicate that the beta-adrenoreceptor-mediated activation of PKA in the 900 g supernatant fraction of human fibroblasts is mediated via beta-adrenoreceptors. The activation of PKA by isoproterenol is very rapid with maximal stimulation occurring at 5 seconds. The time course of PKA activation by isoproterenol in fibroblasts from patients with major depression is identical to that in fibroblasts from normal subjects but the magnitude of activation is significantly reduced in fibroblasts from patients with major depression. Dose-response curves on cyclic AMP mediated activation of PKA confirmed the previously reported reduction in activation of PKA in patients with major depression but demonstrated that this reduction occurs without a change in the EC50 values of cyclic AMP (approximately 20 nmol/L). The blunted beta-adrenoceptor-linked PKA responses in patients with major depression occur without a change in the expression of the PKA catalytic subunit Calpha. The studies suggest that the beta-adrenoceptor-coupled adenylate cyclase PKA system in human fibroblasts may represent a valid model to explore possible abnormalities in the fine tuning of the beta-adrenergic transduction cascade in patients with affective disorders. Ó American College of Neuropsychopharmacology

Keywords: Human fibroblasts; Major depression; Cyclic AMP; Isoproterenol; Protein kinase A (PKA); β-adrenoceptor subtype
  top go to top
Article Links
Send to a friend Send to a friend
Download PDF Download PDF
 Next Article Next Article
 Previous Article Previous Article
 Table of Contents Table of Contents
Privacy Policy Copyright © 1996 by the American College of Neuropsychopharmacology